Old Web
English
Sign In
Acemap
>
authorDetail
>
Melody L. Smart
Melody L. Smart
University of Texas MD Anderson Cancer Center
Pathology
Medicine
Breast cancer
Targeted therapy
Proportional hazards model
3
Papers
30
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Phase I trial of sorafenib, bevacizumab, and temsirolimus in advanced solid tumors.
2017
Journal of Clinical Oncology
Shannon Neville Westin
Melody L. Smart
Navdeep Pal
Diana L. Urbauer
Filip Janku
Jennifer J. Wheler
Sarina Anne Piha-Paul
Aung Naing
Apostolia Maria Tsimberidou
Siqing Fu
Gerald S. Falchook
David Sanghyun Hong
Ralph Zinner
Vivek Subbiah
Kirk S. Culotta
Karen H. Lu
Robert L. Coleman
Razelle Kurzrock
Show All
Source
Cite
Save
Citations (4)
Mesothelin expression and survival outcomes in triple-receptor negative breast cancer.
2017
Journal of Clinical Oncology
Napa Parinyanitikul
George R. Blumenschein
Yun Wu
Xiudong Lei
Mariana Chavez-Mac Gregor
Melody L. Smart
Ana M. Gonzalez-Angulo
Show All
Source
Cite
Save
Citations (0)
Mesothelin expression and survival outcomes in triple receptor negative breast cancer.
2013
Clinical Breast Cancer
Napa Parinyanitikul
George R. Blumenschein
Yun Wu
Xiudong Lei
Mariana Chavez-MacGregor
Melody L. Smart
Ana M. Gonzalez-Angulo
Show All
Source
Cite
Save
Citations (26)
1